相关实验视频
Updated: May 29, 2025
06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
106
在眼科疾病中,阿尔特米西宁的治疗应用
Hao Sun1,2, Ping Zhao1,3,4,5, Lianghui Zhao1,3,4
1Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250000, China.
Heliyon
|February 6, 2025
概括
来自Artemisia annua的Artemisinin,通过调节关键的生物通路来治疗各种眼睛疾病,显示出有前途的希望. 需要进一步的临床研究来确认其在眼科中的治疗潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 眼科医生 眼科 眼科
- 自然产品化学 自然产品化学
背景情况:
- 阿尔特米西宁是一种来自Artemisia annua的甲烯乳,具有多样化的生物活性.
- 新兴的研究突出显示了阿尔特米西宁在治疗眼科相关疾病方面的潜力.
- 它的治疗效果与多种信号通路和生物因素的调节有关.
研究的目的:
- 审查艺术素在眼科疾病的应用方面的最新进展.
- 探索阿尔特米西宁在各种眼睛疾病中的作用机制.
- 为眼科中阿尔特米西宁的临床使用提供理论支持.
主要方法:
- 关于艺术素和眼睛疾病的最新研究的文献综述.
- 分析素在调节信号通路中的作用 (例如,Nrf2/HO-1/Keap1,TLR/MyD88/NF-κb).
- 检查素对生物因素 (如VEGF,TNF-α) 的影响.
主要成果:
- 艺术素在包括紫外炎,与年龄相关的黄斑变性和糖尿病视网膜病变在内的疾病中表现出治疗效果.
- 研究表明,素调节了参与眼部疾病病原发生的关键途径.
- 目前的证据主要来自体外和动物研究,临床数据有限.
结论:
- 甲美西宁在治疗一系列眼科疾病方面具有显著的潜力.
- 进一步的临床试验至关重要,以验证其在人类受试者的有效性和安全性.
- 这一审查支持未来在眼科中大规模应用阿尔特米西宁.
相关概念视频
01:27Open Angle Glaucoma: Treatment
387
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
387
01:26Cholinergic Antagonists: Therapeutic Uses
704
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
704
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
674
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
674
01:28Angle Closure Glaucoma: Treatment
432
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
432
01:24Cholinergic Antagonists: Pharmacokinetics
403
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
403
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
610
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
610